admission date:  [2175-7-11]              discharge date:   [2175-7-19]date of birth:  [2109-7-12]             sex:   mservice: surgeryallergies:patient recorded as having no known allergies to drugsattending:[first name3 (lf) 695]chief complaint:hcc/hcvmajor surgical or invasive procedure:liver transplanthistory of present illness:the patient is a 65-year-old male, with a history of hepatitis c-related cirrhosis,who subsequently developed hepatocellular carcinoma that hasundergone radiofrequency ablation. the patient was evaluatedfor liver transplantation and was found to be a suitablecandidate. he was placed on the waiting list. a suitabledonor has become available, and the patient is now brought tothe operating room after informed consent was obtained fororthotopic deceased donor liver transplant.past medical history:blindness [3-2] retinitis pigmentosa, deafness, hcv/hcc w/ cirr,arthritis, h/o testicular casocial history:married with 2 children and 2grandchildren. no alcohol no tobaccophysical exam:nad aox3cta b/lrrrsoft, ntndno c/c/epertinent results:[2175-7-11] 10:45am blood wbc-5.1 rbc-4.90 hgb-15.3 hct-45.8 mcv-94mch-31.2 mchc-33.4 rdw-13.7 plt ct-96[2175-7-12] 02:00am blood wbc-11.7 rbc-3.67 hgb-11.5 hct-33.9mcv-92 mch-31.2 mchc-33.8 rdw-14.7 plt ct-201[2175-7-13] 03:17am blood wbc-16.9 rbc-3.03 hgb-9.7 hct-27.1mcv-89 mch-31.8 mchc-35.6 rdw-15.4 plt ct-117[2175-7-16] 06:35am blood wbc-7.2 rbc-3.13 hgb-9.7 hct-28.5mcv-91 mch-30.9 mchc-33.9 rdw-14.6 plt ct-110[2175-7-11] 10:45am blood pt-12.9 ptt-31.3 inr(pt)-1.1[2175-7-12] 03:20am blood pt-19.5 ptt-90.0 inr(pt)-1.9[2175-7-18] 04:35am blood pt-12.3 ptt-21.1 inr(pt)-1.1[2175-7-11] 10:45am blood fibrino-105[2175-7-12] 05:20am blood fibrino-159[2175-7-15] 07:00am blood fibrino-302[2175-7-13] 01:00pm blood glucose-186 urean-20 creat-0.7 na-140k-4.4 cl-106 hco3-26 angap-12[2175-7-18] 04:35am blood glucose-147 urean-26 creat-0.8 na-141k-4.2 cl-110 hco3-23 angap-12[2175-7-11] 10:45am blood alt-43 ast-86 alkphos-308 totbili-1.0[2175-7-12] 11:55am blood alt-511 ast-642 alkphos-107 totbili-0.8dirbili-0.4 indbili-0.4[2175-7-14] 04:47am blood alt-261 ast-132 alkphos-113 totbili-0.5[2175-7-18] 04:35am blood alt-203 ast-51 alkphos-187 totbili-0.4[2175-7-12] 05:20am blood albumin-2.6 calcium-9.3 phos-1.6 mg-1.8[2175-7-18] 04:35am blood albumin-3.1 calcium-8.4 phos-3.5 mg-1.7[2175-7-18] 04:35am blood afp-13.7[2175-7-13] 07:25am blood fk506-3.8[2175-7-18] 04:35am blood fk506-11.2[2175-7-11] 10:53am urine blood-lg nitrite-neg protein-negglucose-neg ketone-neg bilirub-neg urobiln-neg ph-6.5 leuks-neg[2175-7-11] 10:53am urine color-yellow appear-clear sp [last name (un) ]-1.013[2175-7-11] 02:04pm urine rbc-[4-2] wbc-0-2 bacteri-occ yeast-noneepi-0[2175-7-16] 10:45 am immunology (cmv)                            final report [2175-7-18]   cmv viral load (final [2175-7-18]):      cmv dna not detected.      name birthdate    age     sex pathology #     [hospital1 18] [known lastname 65394],[known firstname ]       [2109-7-12]    65 male      [-6/2320] [numeric identifier 65395]report to:   dr. [last name (stitle) ] [last name (namepattern4) ]gross description by:   dr. [last name (stitle) ] [last name (namepattern4) ]/difspecimen submitted:  recipient liver & donor liver bx.procedure date     tissue received     report date    diagnosedby[2175-7-11] [2175-7-12] [2175-7-18] dr. [last name (stitle) ] [last name (namepattern4) ]/cma??????previous biopsies:    [numeric identifier 65396]  consult slides referred to dr.[last name (stitle) ]. [doctor last name ].diagnosis1.  liver, native hepatectomy (a-j):a.  one nodule (3.0 cm) of moderately differentiatedhepatocellular carcinoma with features consistent withradiofrequency ablation effect.  the tumor is predominantly(>95%) necrotic with rare microscopic foci of viable component.b.  one focus of venous invasion seen is a portal vein away fromthe tumor.c.  established cirrhosis with grade [1-30] inflammation. trichromestain evaluated.d.  iron stain shows minimal iron deposition in kupffer cells.e.  gallbladder with mild chronic cholecystitis.2.  donor liver, needle biopsy (k):a.  liver parenchyma with no significant inflammation or fattychanges seen.b.  trichrome stain shows no significant fibrosis.duplex dopp abd/pel  [2175-7-12] 10:27 amliver or gallbladder us (singl; -59 distinct procedural servicreason: s/p liver transplant ,eval for vasculature flow andpatency[hospital 93] medical condition:66 year old man s/p liver transplant day 0reason for this examination:duplex - please evaluate vasculature flow and patencyindication: 66-year-old male status post liver transplant.technique: the liver transplant was performed.liver transplant ultrasound:findings: the portal vein is patent and has normal direction offlow. the hepatic artery and its branches are patent. thehepatic veins are patent. no obvious fluid collections or freefluid is seen.impression: normal liver transplant ultrasound.liver or gallbladder us (single organ)  [2175-7-16] 2:52 pmliver or gallbladder us (singl; duplex dopp abd/pelreason: please do duplex? rejection ?thrombus/clot[hospital 93] medical condition:66 year old man s/p liver transplant with increasing lftsreason for this examination:please do duplex? rejection ?thrombus/clotindication: 66-year-old man status post liver transplant withincreasing liver function tests. evaluate.comparison: [2174-7-12].liver ultrasound with doppler examination: the liver parenchymais normal in echogenicity, without focal nodules or masses. anew 2.9 x 1.1 x 1.4 cm echogenic nodule is seen within theregion of the excluded donor ivc most consistent with thrombus.superior extension to the recipient ivc anastomosis is notclearly identified, and follow-up imaging is recommended. theadjacent recipient ivc is patent. the right, middle, and lefthepatic veins demonstrate normal direction of flow andrespiratory variation. the main, posterior right, anteriorright, and left portal veins are patent, with appropriatedirection of flow. the main, right, and left hepatic arteriesdemonstrate normal systolic upstroke with resistive indicesmeasuring 0.83, 0.72, and 0.83, respectively.impression:1. normal liver doppler study.2. new thrombus within excluded donor ivc. proximal extensioninto the recipient ivc is not clearly defined, and follow-upimaging is recommended for further evaluation.specimen submitted:  liver biopsy (same day rush)procedure date     tissue received     report date    diagnosedby[2175-7-17] [2175-7-17] [2175-7-17] dr. [last name (stitle) ] [last name (namepattern4) ]/claprevious biopsies:    [-6/2320]  recipient liver & donor liverbx.  [numeric identifier 65396]  consult slides referred to dr. [last name (stitle) ]. [doctor last name ].diagnosis:liver, allograft, needle core biopsy:liver parenchyma with no significant portal or lobularinflammation.no fatty change or features of preservation/ischemic injury areseen.no features of acute cellular rejection are seen.brief hospital course:patient was taken to the operating room and underwent anorthotopic liver transplant; the patient only required 1 unit ofpacked cells, 2 units ofplatelets, 500-cc of albumin, and 1 unit of cryo intraop. he wastaken to the apcu intubated and in stable condition. patient didextremely well and was therefore extubated later that day (aheadof the pathway). he stayed in the icu for monitoring for another24hours, and was then transferred to the floor late on pod1.from here he made a remarkabel recovery. he continued to makegood urine and lfts went downward for the first few days. heambulated with assitance and tolerated good po pretty early.some hampering to his recovery was the fact that he is blind andsomewhat deaf - he was continually claiming to be depressedbecause of boredom and lonliness. duplex on pod1 was normal, andcxrs continued to be normal. his cvl was removed before he leftthe icu. on pod5 his lfts bumped up slightly, so he recieved 2boluses of steroids as a precautionary measure and a repeat uswas performed which showed a mural thrombus in the donor ivc.biopsy was done which was normal and without signs of rejection.after that, lfts started to decline again and patient continuedto do extremely well.medications on admission:citracal 600'', mycelox 5x/d, cod liver oildischarge disposition:home with servicefacility:southern [hospital 1727] medical vnadischarge diagnosis:hcv/hccdeafblinddischarge condition:stabledischarge instructions:call transplant office [telephone/fax (1) 673] if fevers, chills, nausea,vomiting, redness/bleeding/drainage from incision or old drainsites, jaundice,  increased abdominal pain or any questions.labs every monday & thursday for cbc, chem 10, ast, alt, alkphos, t.bili,albumin and trough prograf level. fax results to[hospital1 18] transplant office attn: [first name8 (namepattern2) 1022] [last name (namepattern1) ] rn [telephone/fax (1) 697]followup instructions:provider: [first name11 (name pattern1) ] [last name (namepattern4) 707], md, phd[md number(3) 708]:[telephone/fax (1) 673]date/time:[2175-7-26] 2:40provider: [first name11 (name pattern1) ] [last name (namepattern4) 707], md, phd[md number(3) 708]:[telephone/fax (1) 673]date/time:[2175-8-2] 2:00provider: [first name11 (name pattern1) ] [last name (namepattern4) 707], md, phd[md number(3) 708]:[telephone/fax (1) 673]date/time:[2175-8-9] 2:00                             [first name11 (name pattern1) ] [last name (namepattern4) 707] md, [md number(3) 709]completed by:[2175-7-26]